These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8809474)

  • 1. Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up.
    Liu Z; Hultin LE; Cumberland WG; Hultin P; Schmid I; Matud JL; Detels R; Giorgi JV
    Cytometry; 1996 Mar; 26(1):1-7. PubMed ID: 8809474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens.
    Ho HN; Hultin LE; Mitsuyasu RT; Matud JL; Hausner MA; Bockstoce D; Chou CC; O'Rourke S; Taylor JM; Giorgi JV
    J Immunol; 1993 Apr; 150(7):3070-9. PubMed ID: 8454874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years.
    de Martino M; Rossi ME; Azzari C; Gelli MG; Galli L; Vierucci A
    Pediatr Res; 1998 Jun; 43(6):752-8. PubMed ID: 9621984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of CD8(+) T-cell subsets in HIV-infected rapid progressor children versus non--rapid progressor children.
    Paul ME; Shearer WT; Kozinetz CA; Lewis DE
    J Allergy Clin Immunol; 2001 Aug; 108(2):258-64. PubMed ID: 11496243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+CD38+ and CD8+DR+ peripheral blood lymphoid subsets of HIV-infected intravenous drug abusers correlate with CD4+ cell counts and proliferation to mitogens.
    Echaniz P; Arrizabalaga J; Iribarren JA; Cuadrado E
    Cell Immunol; 1993 Aug; 150(1):72-80. PubMed ID: 7688270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD38 expression on CD8(+) T cells as a prognostic marker in vertically HIV-infected pediatric patients.
    Sherman GG; Scott LE; Galpin JS; Kuhn L; Tiemessen CT; Simmank K; Meddows-Taylor S; Meyers TM
    Pediatr Res; 2002 Jun; 51(6):740-5. PubMed ID: 12032270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study.
    Giorgi JV; Liu Z; Hultin LE; Cumberland WG; Hennessey K; Detels R
    J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):904-12. PubMed ID: 7686224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.
    Liu Z; Cumberland WG; Hultin LE; Prince HE; Detels R; Giorgi JV
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Oct; 16(2):83-92. PubMed ID: 9358102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes.
    Plaeger S; Bass HZ; Nishanian P; Thomas J; Aziz N; Detels R; King J; Cumberland W; Kemeny M; Fahey JL
    Clin Immunol; 1999 Feb; 90(2):238-46. PubMed ID: 10080836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cd38 expression on Cd8+ T cells in Human immunodeficiency virus 1-positive adults treated with HAART.
    Beran O; Holub M; Spála J; Kalanin J; Stanková M
    Acta Virol; 2003; 47(2):121-4. PubMed ID: 14524479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrest of in vitro T cell differentiation of normal bone marrow-derived CD34+ stem cells with thymic epithelial fragments from children with AIDS.
    Ruiz ME; Freeman J; Bouhasin JD; Knutsen AP; Hendrix MJ
    Stem Cells; 1996 Sep; 14(5):533-47. PubMed ID: 8888494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver.
    Roy V; Miller JS; Verfaillie CM
    Exp Hematol; 1997 May; 25(5):387-94. PubMed ID: 9168060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: findings from the first year of the CIPRA-SA cohort.
    Glencross DK; Janossy G; Coetzee LM; Lawrie D; Scott LE; Sanne I; McIntyre JA; Stevens W
    Cytometry B Clin Cytom; 2008; 74 Suppl 1():S131-40. PubMed ID: 18228566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD38 expression in CD8+ T cells predicts virological failure in HIV type 1-infected children receiving antiretroviral therapy.
    Resino S; Bellón JM; Gurbindo MD; Muñoz-Fernández MA
    Clin Infect Dis; 2004 Feb; 38(3):412-7. PubMed ID: 14727214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of CD38 activation antigen expression on CD8+ T cells in HIV-1 infection using CD4 expression on CD4+ T lymphocytes as a biological calibrator.
    Hultin LE; Matud JL; Giorgi JV
    Cytometry; 1998 Oct; 33(2):123-32. PubMed ID: 9773872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for B cell-mediated activation of V delta 1+ T lymphocytes during progression of HIV infection.
    Hyjek EM; Bartkowiak J; Drozdz R; Wasik TJ; Jasinski M; Kaneko Y; Lischner HW; Kozbor D
    J Immunol; 1997 Jan; 158(1):464-74. PubMed ID: 8977224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive infection in a subset of HIV-1-positive chimpanzees.
    O'Neil SP; Novembre FJ; Hill AB; Suwyn C; Hart CE; Evans-Strickfaden T; Anderson DC; deRosayro J; Herndon JG; Saucier M; McClure HM
    J Infect Dis; 2000 Oct; 182(4):1051-62. PubMed ID: 10979899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
    Kaufmann GR; Zaunders JJ; Cunningham P; Cooper DA
    AIDS Res Hum Retroviruses; 1999 Jul; 15(11):963-72. PubMed ID: 10445808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multisite comparison of methods for the quantitation of the surface expression of CD38 on CD8(+) T lymphocytes. The ACTG Advanced Flow Cytometry Focus Group.
    Schmitz JL; Czerniewski MA; Edinger M; Plaeger S; Gelman R; Wilkening CL; Zawadzki JA; Wormsley SB
    Cytometry; 2000 Jun; 42(3):174-9. PubMed ID: 10861690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.